300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
InsurTech
Platforms
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
Hospitality
eSports
Construction
Biotechnology
Consumer
Renewable Energy
Software
Crowdfunding
Theatre
Venture Capital
Medical
Recruiting
Web3
Fashion
Cannabis
LGBT
Celebrity
Social
Climate
Mobile Apps
Life Science
Wine and Spirits
Food and Beverage
Publishing
Beauty
Music
Art
Real Estate
Infrastructure
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Social Media
Mobile Advertising
Franchise
Android
Sustainability
Hardware
Biotech
Impact
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Non Profit
Internet
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Taiwan
Tunisia
Sweden
Zimbabwe
Zambia
Norway
Tajikistan
Mexico
Nigeria
Russian Federation
Togo
Guinea
Nepal
Isle of Man
Iran
Madagascar
Romania
Pakistan
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
China
Armenia
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Mauritius
Namibia
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Morocco
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Turkey
Uruguay
Uganda
Seychelles
Moldova
Botswana
Paraguay
Ireland
Japan
South Africa
France
Georgia
Denmark
Canada
Ghana
Iraq
Mali
Latvia
United Kingdom
Malaysia
Portugal
Sierra Leone
Philippines
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Argentina
Spain
Angola
Europe
Cyprus
Qatar
Belgium
Bangladesh
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bolivia
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Algeria
Finland
Italy
Belarus
Belize
Hungary
Grenada
Israel
Iceland
Liechtenstein
Lebanon
Cambodia
Honduras
Lithuania
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotech Startup Investors in Austria (August 2026)

The most active venture capital funds and angel investors investing in Austria Biotech startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Austria Biotech startup companies. Find investors to raise a Pre-Seed, Seed or Series A round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
XISTA Science Ventures
VC Fund
17 Austria, Germany, France Seed, Pre-Seed, Series A Biotechnology, Medical, Software $511k–$20M
xista science ventures
VC Fund
9 Austria, Slovenia Seed, Pre-Seed, Series A Biotechnology, Medical, Software $511k–$20M
tecnet equity
VC Fund
9 Austria Seed, Series A Software, Biotechnology, Health Care $400k–$20M
austria Wirtschaftsservice (aws)
VC Fund
6 Austria, Belgium Seed, Grant, Pre-Seed Software, Information Technology, Artificial Intelligence $62k–$2.8M
SOSV
VC Fund
5 United States, India, United Kingdom Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Software
aws Gründungsfonds
VC Fund
4 Austria, Germany, United States Seed, Series A Software, SaaS, Information Technology $1.1M–$11M
MIG Capital
VC Fund
4 Germany, France, Austria Series A, Series B Biotechnology, Health Care, Software $1.6M–$60M
10x Founders
VC Fund
3 Germany, United States, Switzerland Seed, Series A, Pre-Seed Software, Artificial Intelligence, Information Technology $1.1M–$60M
Lansdowne Partners
VC Fund
3 United Kingdom, Austria, United States Series A, Series B Biotechnology, Finance, Genetics $6.7M–$100M
Schnidar Harald
Angel
3 Austria Seed, Angel, Pre-Seed mHealth, Software, Biopharma
PUSH VC
VC Fund
3 Austria, Germany, United States Seed, Series A Software, Apps, Health Care $650k–$31M
FPS-Holding
VC Fund
3 Austria Seed Biotechnology, Health Diagnostics $420k–$1.5M
Aescap Venture
VC Fund
2 United Kingdom, Austria, Belgium Series A, Series B Biotechnology, Pharmaceutical, Chemical $1.5M–$33M
APEX Ventures
VC Fund
2 Germany, United Kingdom, Austria Seed, Series A, Pre-Seed Artificial Intelligence, Software, Health Care $511k–$22M
TSVC
VC Fund
2 United States, China, Canada Seed, Series A Software, Artificial Intelligence, Health Care $500k–$55M
The Austrian Research Promotion Agency (FFG)
VC Fund
2 Austria, United States, Belgium Grant, Seed, Pre-Seed Software, Artificial Intelligence, Medical $67k–$3.5M
Gamma Capital Partners
VC Fund
2 Austria, United States, Germany Series A, Seed Software, Manufacturing, Information Technology $406k–$8M
HTGF (High-Tech Gruenderfonds)
VC Fund
2 Germany, Switzerland, United States Seed, Series A Software, Biotechnology, Information Technology $909k–$39M
GreyBird Ventures
VC Fund
2 United States, China, Israel Series A, Seed Health Care, Medical, Biotechnology $3M–$16M
Open Field Capital
VC Fund
2 United States, Austria, United Kingdom Series A, Seed Artificial Intelligence, Software, Health Care $3.1M–$52M
bmp Ventures
VC Fund
2 Germany, United States, Austria Seed, Series A Software, Information Technology, Manufacturing $30k–$5.9M
R42 Group
VC Fund
2 United Kingdom, United States, Austria Seed, Pre-Seed, Series A Biotechnology, Health Care, Software $472k–$40M
ICL Planet Startup Hub
VC Fund
2 Israel, Austria Seed Biotechnology, Agriculture, AgTech $4.3M–$10M
Ligand Pharmaceuticals
VC Fund
2 United States, Austria, Denmark Post-IPO Debt, Corporate Round, Post-IPO Equity Biotechnology, Medical, Health Care $3M–$90M
red-stars.com
VC Fund
2 Austria, Germany Seed, Series A Software, Biotechnology, Telecommunications $1.8M–$4.4M
eQventure
VC Fund
2 Austria, Germany, Switzerland Seed, Series A Software, Information Technology, Artificial Intelligence $540k–$6.3M
VP Venture Partners
VC Fund
2 Austria, Switzerland Seed Medical, Health Diagnostics, Internet $3M–$6.9M
BackBone Ventures
VC Fund
2 Switzerland, Germany, Israel Pre-Seed, Seed, Series A Artificial Intelligence, Software, Information Technology $578k–$105M
Verge HealthTech Fund
VC Fund
2 Estonia, Singapore, United Kingdom Seed, Pre-Seed, Series A Health Care, Medical Device, Medical $500k–$4.7M
Simon Capital
VC Fund
2 Germany, Austria, The Netherlands Series A, Seed, Series B Software, Biotechnology, Food and Beverage $1.7M–$57M
Nina Capital
VC Fund
2 United States, United Kingdom, Germany Seed, Pre-Seed, Series A Health Care, Artificial Intelligence, Software $529k–$21M
KHAN Technology Transfer Fund
VC Fund
2 Germany, Austria, Luxembourg Seed, Pre-Seed, Series A Biotechnology, Medical, Biopharma $259k–$10M
Arax Capital Partners
VC Fund
2 Austria Seed Biotechnology, Health Care, SaaS $1.1M–$1.1M
Hadean Ventures
VC Fund
2 Norway, Sweden, Austria Series A, Series B Biotechnology, Health Care, Medical $4.3M–$79M
Longevitytech.fund
VC Fund
2 United States, United Kingdom, The Netherlands Seed, Convertible Note, Pre-Seed Biotechnology, Health Care, Life Science $100k–$10M
SkyGene
VC Fund
2 Austria Venture - Series Unknown Medical, Health Care, Biotechnology
Übermorgen Ventures
VC Fund
2 Germany, Switzerland, Finland Seed, Pre-Seed, Series A Energy, Software, SaaS $300k–$12M
Amino Collective
VC Fund
1 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Biotechnology, Health Care, Artificial Intelligence $125k–$37M
Air Street Capital
VC Fund
1 United States, United Kingdom, France Seed, Series A, Series B Artificial Intelligence, Software, Biotechnology $2.6M–$300M
Andera Partners
VC Fund
1 France, United States, Germany Series B, Private Equity, Series A Biotechnology, Health Care, Medical $7M–$237M
Polaris Partners
VC Fund
1 United States, Ireland, Singapore Series B, Series A, Series C Biotechnology, Health Care, Medical $4.5M–$107M
Forbion Capital Partners
VC Fund
1 United States, United Kingdom, The Netherlands Series B, Series A, Series C Biotechnology, Health Care, Medical $16M–$180M
OrbiMed
VC Fund
1 United States, China, Israel Series B, Series A, Series C Biotechnology, Health Care, Medical $10M–$183M
Venture Partners AG
VC Fund
1 Austria, United States Seed, Series B Internet, Software, Biotechnology
PONTIS Venture Partners Management
VC Fund
1 Austria, Germany Series A, Series B, Series C Software, Manufacturing, Information Technology
IPO Beteiligungs-Management
VC Fund
1 Austria Series B Sensor, Medical, Wireless
Axilium Holding
VC Fund
1 Austria Seed Life Science, Biotechnology, Semiconductor
IBG Beteiligungsgesellschaft Sachsen-Anhalt
VC Fund
1 Germany, Austria Seed, Series A Electronics, Software, Medical Device
ReGen Ventures
VC Fund
1 United States, Austria, United Kingdom Seed, Series A, Series B Agriculture, Biotechnology, Farming
Climentum Capital
VC Fund
1 Sweden, Spain, Austria Seed, Series A, Series B CleanTech, Clean Energy, Biotechnology
Access all 191 investors in Austria Biotech startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

XISTA Science Ventures
VC Fund · Klosterneuburg, Niederosterreich, Austria · 17 investments in Austria Biotech startups

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, Germany, France

Investor stats

  • Total investments: 45
  • Round size: Seed $1.8M–$6.9M; Pre-Seed $511k–$2.3M; Series A $5.7M–$20M
  • Lead/follow: 58% lead, 42% follow

Portfolio highlights

  • Ribbon Bio — Making The Impossible Possible
  • Rivus Batteries — Rivus is a start-up that serves as the commercialization platform for the aqueous organic flow battery technology.
  • G.ST Antivirals — G.ST Antivirals focuses on the development of antiviral drugs. G.ST Antivirals utilizes the viral dependency on the host cell metabolism and exploits this to design specific interventions counteracting viral nutrient supply.
Show all investments...

xista science ventures
VC Fund · Klosterneuburg, Niederosterreich, Austria · 9 investments in Austria Biotech startups

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Austria, Slovenia

Investor stats

  • Total investments: 22
  • Round size: Seed $1.8M–$7.3M; Pre-Seed $511k–$1.5M; Series A $5.7M–$20M
  • Lead/follow: 64% lead, 36% follow

Portfolio highlights

  • subdron — subdron turns the seabed from a blind spot into a monitored domain.
  • infrared.city — Redefine environmental simulations. Our bespoke AI models revolutionise performative design, slashing time, cost, and complexity. Access cutting-edge services effortlessly because innovation should be for everyone
  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

tecnet equity
VC Fund · Sankt Polten, Niederosterreich, Austria · 9 investments in Austria Biotech startups

tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: Austria

Investor stats

  • Total investments: 71
  • Round size: Seed $400k–$2.5M; Series A $583k–$20M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: May invest from a new fund soon — last raise in 2009

Portfolio highlights

  • PROPCORN AI — At PROPCORN, our goal is to harness the power of AI to automatically unlock the full real estate building potential of our customers, enabling them to make faster and more accurate decisions in real-time.
  • Ribbon Bio — Making The Impossible Possible
  • Greenwood-Power — Greenwood-Power is the leading innovator for non-conventional transformers. Let's talk about your individual requirements - CONTACT US TODAY!
Show all investments...

austria Wirtschaftsservice (aws)
VC Fund · Vienna, Wien, Austria · 6 investments in Austria Biotech startups, 8 in the past 12 months

The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Grant, Pre-Seed
  • Geography: Austria, Belgium

Investor stats

  • Total investments: 70
  • Round size: Seed $439k–$2.8M; Grant $62k–$2.3M; Pre-Seed $195k–$1.6M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • Repentium — We strive to create
  • Graph Therapeutics — Graph Therapeutics - precision immunology
  • Epitome Therapeutics — Epitome Therapeutics is an early-stage biotechnology company developing CADENCE, a next-generation epigenome editing platform for precise, durable, and context-dependent control of gene expression without altering the underlying DNA sequence, with the aim of establishing a new therapeutic modality for diseases driven by dysregulated gene activity.
Show all investments...

SOSV
VC Fund · Princeton, New Jersey, United States · 5 investments in Austria Biotech startups, 75 in the past 12 months

SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 1482
  • Lead/follow: no public data

Portfolio highlights

  • MixRift — MIXRIFT - game developers specialized in Mixed Reality
  • unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
  • Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Show all investments...

aws Gründungsfonds
VC Fund · Vienna, Wien, Austria · 4 investments in Austria Biotech startups

aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.

Show more...

Investment focus

  • Industry: Software, SaaS, Information Technology
  • Stage:Seed, Series A
  • Geography: Austria, Germany, United States

Investor stats

  • Total investments: 91
  • Round size: Seed $1.3M–$5.2M; Series A $1.1M–$11M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • refinq — Our platform helps companies transform climate and biodiversity risks into opportunities to reduce costs, future-proof operations, and stay competitive.
  • vitrealab — Enlighten. Your perspective. Light Engines for AR glasses.
  • Invisible-Light Labs — Invisible Light Labs uses Fourier transform infrared (FTIR) spectroscopy and nanoelectromechanical sensing technologies to enable chemical analysis of materials and nanomaterials that are available in minuscule amounts in a variety of industries, from environmental monitoring to pharmaceuticals.
Show all investments...

MIG Capital
VC Fund · München, Bayern, Germany · 4 investments in Austria Biotech startups

MIG Capital is one of the leading German VC Investors. We invest in European Deep Tech and Life Sciences from early to late stage (Seed, Series A, and beyond). We use investments to shape a better tomorrow, today. Our team currently manages 17 MIG public venture capital funds regulated by BaFin, the German financial markets authority. These fundsoperate with more than EUR 1.2 billion capital committed by >60,000 private investors across Germany and Austria.Today, our portfolio consists of 30 companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: Germany, France, Austria

Investor stats

  • Total investments: 97
  • Round size: Series A $2.2M–$40M; Series B $1.6M–$60M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: May invest from a new fund soon — raised $70M in 2014

Portfolio highlights

  • NcodiN — The High Performance Computing (HPC) and ArtificiaI Intelligence (AI) era requires unprecedented computing capabilities. With this in view, industry is heading towards zettascale supercomputers, based on >100k processing units. Chiplets-based disaggregated processors and memory-centric computing architectures are taking over and require an ever more intensive communication between dies. Thus, today interconnect bottleneck is the main
  • GlassPoint Solar — GlassPoint provides solar steam generators to the oil and gas industry for applications such as Enhanced Oil Recovery. It replaces gas-fired steam generation with solar, GlassPoint can reduce EOR gas consumption by up to 80 percent. The company was founded in 2008 and headquartered in Fremont, California.
  • Zadient Technologies — Zadient produces semiconductor manufacturing materials that are critical for the entire silicon carbide (SiC) value chain
Show all investments...

10x Founders
VC Fund · Munich, Bayern, Germany · 3 investments in Austria Biotech startups, 7 in the past 12 months

Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United States, Switzerland

Investor stats

  • Total investments: 92
  • Round size: Seed $2.5M–$10M; Pre-Seed $1.1M–$12M; Series A $6.7M–$60M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Logicc — Logicc provides business solutions for various industries. It specializes in software development, automation, and data-driven technologies.
  • Qorelo — Qorelo helps enterprise SAP teams accelerate S/4HANA migration, automate fit-gap analysis, map SAP scope, generate documentation, and guide continuous improvement after go-live.
  • Songscription — Play, learn & share the music you love. AI-powered audio transcription into sheet music, MIDI & piano roll for musicians, educators and creators.
Show all investments...

Lansdowne Partners
VC Fund · London, England, United Kingdom · 3 investments in Austria Biotech startups

Fundamental Equity Investing, since 1998

Show more...

Investment focus

  • Industry: Biotechnology, Finance, Genetics
  • Stage:Series A, Series B
  • Geography: United Kingdom, Austria, United States

Investor stats

  • Total investments: 45
  • Round size: Series A $6.7M–$55M; Series B $8.5M–$100M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Nattergal — Nattergal delivers BNG Units and nature restoration at scale through rewilding, habitat creation and natural capital solutions.
  • MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
  • amnis — Check out your possibilities to transfer money abroad, collect international payments and exchange currencies all in one account. Make payments fast with amnis.
Show all investments...

Schnidar Harald
Angel · Vienna, Wien, Austria · 3 investments in Austria Biotech startups

Entrepreneur, Angel Investor, Scientist and Inventor

Show more...

Investment focus

  • Industry: mHealth, Software, Biopharma
  • Stage:Seed, Angel, Pre-Seed
  • Geography: Austria

Investor stats

  • Total investments: 7
  • Lead/follow: 86% lead, 14% follow

Portfolio highlights

  • SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
PUSH VC
VC Fund · Vienna, Wien, Austria · 3 investments in Austria Biotech startups

We are an early-stage Venture Capital Firm investing in outstanding teams with convincing products and high growth potential.

Show more...

Investment focus

  • Industry: Software, Apps, Health Care
  • Stage:Seed, Series A
  • Geography: Austria, Germany, United States

Investor stats

  • Total investments: 45
  • Round size: Seed $650k–$8.1M; Series A $5M–$31M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Gustav — Modern staffing teams use Gustav's VMS to source talent from trusted sub-vendors. Fast, secure, and compliant!
  • Voltrac — Building electric autonomous vehicles for farming & frontline logistics
  • enspired — Revolutionize battery storage with AI-powered BESS optimization. Our energy trading platform ensures smart, real-time market access. Contact us today!
Show all investments...

FPS-Holding
VC Fund · 3 investments in Austria Biotech startups

Investment focus

  • Industry: Biotechnology, Health Diagnostics
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 3
  • Round size: Seed $420k–$1.5M
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Sola Diagnostics — Product: Sola Diagnostics’ WID®-easy test is a non-invasive epigenetic solution for detecting endometrial cancer in women with abnormal uterine bleeding. By analyzing DNA methylation markers from a simple vaginal swab, it offers high accuracy, reducing false positives and unnecessary surgeries. Target Audience: Designed for gynecologists andhealthcare providers, WID®-easy streamlines diagnostics, cutting costs and false alarms. Women benefit from a painless, accessible test that ensures earlier and more precise detection. Technology: Powered by advanced DNA methylation research, WID®-easy identifies cancer-specific epigenetic markers. With PCR-based analysis and robust clinical validation, it delivers fast, reliable results that integrate seamlessly into medical workflows. Market Positioning: WID®-easy fills a critical gap as a first-line diagnostic for abnormal uterine bleeding. Its clinical validation, accuracy, and cost-efficiency set it apart from invasive procedures. Its ease of use and scalability position it for widespread adoption. Milestones: Sola Diagnostics launched in Austria and Switzerland in 2024 and expanded to Great Britain in 2025. UKCA Marking was registered in December 2024. So far, private equity investments totaling €2.4M have supported Sola's mission to revolutionize women’s health diagnostics.
Show all investments...

Aescap Venture
VC Fund · Amsterdam, Noord-Holland, The Netherlands · 2 investments in Austria Biotech startups

Aescap Venture is an Amsterdam-based investment company that pursues investments in biotech companies in Europe and the U.S.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Chemical
  • Stage:Series A, Series B
  • Geography: United Kingdom, Austria, Belgium

Investor stats

  • Total investments: 18
  • Round size: Series A $1.5M–$20M; Series B $5.2M–$33M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
  • Affectis Pharmaceuticals — Affectis is a pharmaceuticals company developing novel drugs for the treatment of neurodegenerative and neuroinflammatory diseases.
  • F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.
Show all investments...

APEX Ventures
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

APEX Ventures is a deep-tech and medical focused venture capital firm, run by founders with complimentary backgrounds driven by the same mission.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Seed, Series A, Pre-Seed
  • Geography: Germany, United Kingdom, Austria

Investor stats

  • Total investments: 53
  • Round size: Seed $1.3M–$8M; Pre-Seed $511k–$9.1M; Series A $2.4M–$22M
  • Lead/follow: 32% lead, 68% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • GEMESYS — Gemesys creates a chip that functions similarly to the human brain in order to overcome processing constraints and empower AI with the hardware it needs to complete its destiny
  • HyperHeat — HyperHeat is building a cutting-edge, all-electric heating solution designed to reach temperatures of up to 2,000°C. Using renewable electricity HyperHeat is providing an efficient alternative to fossil fuel combustion. With an efficiency rate of up to 98%, HyperHeat is ideal for retrofitting industrial processes, enabling significant CO2reductions across industries like steel, cement, and chemicals. The scalable technology offers a cost-efficient approach to decarbonizing thermal processes, with a potential to reduce global CO2 emissions by over 4.5 gigatons annually.
  • TriLite Technologies — The world's smallest projection displays from TriLite take laser beam scanning technology to the next level, for augmented vision as light as the eyewear of today.
Show all investments...

TSVC
VC Fund · Los Altos, California, United States · 2 investments in Austria Biotech startups, 14 in the past 12 months

Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Seed, Series A
  • Geography: United States, China, Canada

Investor stats

  • Total investments: 293
  • Round size: Seed $500k–$7M; Series A $2.7M–$55M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Dexmate — Dexmate is a robotics startup focused on developing general-purpose mobile robots. The company specializes in robots with manipulation capabilities. Their technology aims to enhance automation across various industries.
  • EGI Battery — EGI Battery is an American advanced battery cell manufacturer headquartered with design and operations in Ann Arbor, Michigan, U.S.
  • Expert Intelligence — Expert Intelligence develops AI systems to scale expert decision-making in regulated laboratory conditions where data is restricted, stakes are high, and validation is required.
Show all investments...

The Austrian Research Promotion Agency (FFG)
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Medical
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Austria, United States, Belgium

Investor stats

  • Total investments: 70
  • Round size: Seed $300k–$2.2M; Grant $67k–$3.5M; Pre-Seed $480k–$1.9M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • OPTIMUSE — Optimuse provides an AI-based solution that supports the pre-design phase of building renovation. The platform converts building data into a digital twin to create accurate models for planning. It integrates data such as room types, thermal properties, and HVAC systems. The system runs energy simulations to calculate heating, cooling, lighting, andequipment needs. It helps design technical systems by defining the quantity, sizing, and configuration of components. The platform develops renovation plans by modeling financial, energy, and emissions outcomes. It also offers tools for cost calculation, performance monitoring, and collaboration across project teams.
  • sequestra — Sequestra is developing a technology platform that allows for permanent binding of CO₂ in industrial residues such as steel slag, incineration ash, and demolition waste while making the carbonated materials usable for construction applications.
  • Another Earth — Another Earth is building an AI-powered simulation and synthetic data platform for Earth Observation. As our planet changes, AI models need scalable, high-quality training data to keep pace. Another Earth provides synthetic data, scenario simulations and predictions required to accelerate AI development, and enable faster, smarterdecision-making—enabling smarter decisions for a more resilient world.
Show all investments...

Gamma Capital Partners
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

gcp gamma capital partners is an independent Venture Capital investment firm, focused on financing dynamic technology companies in Austria, Germany, Switzerland and CEE countries.They seek to achieve superior returns by finding assets with substantial potential in their regional and sectoral focus areas, before they appear on the radar screenof mainstream players in terms of stage and/or initial investment size.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Seed
  • Geography: Austria, United States, Germany

Investor stats

  • Total investments: 29
  • Round size: Seed $406k–$636k; Series A $1.3M–$8M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Icomasoft — Icomasoft ag is a Swiss pioneer of agent-less software solutions providing unprecedented transparency across your virtual and physical IT infrastructure in heterogeneous datacenters.IcomasoftÂ:registered: software solutions collect essential information for mission-critical and business-critical decisions and provide simplified, automated tasksthat support administrators, IT managers and Executives to easily and confidently analyze, plan and optimize their IT capacity. icomasoftÂ:registered: software solutions are vital for your datacenter clarity.
  • Henn GmbH & Co KG — A connection system manufacturer in Austria. High-quality VDA/SAE couplings for charge air cooling water systems used by OEMs worldwide
  • CNSystems Medizintechnik — Non-invasive, continuous blood pressure & hemodynamics: cardiovascular assessment (syncope), hypotension & fluid management (CNAP technology)
Show all investments...

HTGF (High-Tech Gruenderfonds)
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 2 investments in Austria Biotech startups

High-Tech Grunderfonds finances startups with growth potential. Its team of investment managers supports young companies with expertise, entrepreneurial spirit, and passion. The company focuses in the fields of digital tech, industrial tech, life sciences, chemistry, and related business areas. It also focuses on financial services in varioussectors.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 610
  • Round size: Seed $909k–$7M; Series A $3.5M–$39M
  • Lead/follow: 34% lead, 66% follow
  • Last fund: Likely still investing — raised $522M in 2022

Portfolio highlights

  • CorTec — Reliable products for active implantable device development. We realize your next project with you and offer individual solutions that meet your specific requirements for Medical Devices, especially in neurotechnology.
  • Coinlend — Coinlend - The Lending-Bot for Bitfinex & Liquid Genearate interest from your Bitcoin and Altcoin investments!
  • CenterPoint - Connective Software Engineering — CenterPoint was founded in 2000 and is based in Villach, Austria with an additional office in Warsaw, Poland. CenterPoint - Connective Software Engineering develops and markets process control and fault detection and classification software solutions. The company offers cause effect analysis, metrology assessment, and close loop and run to runcontrol services. It's focus are the semiconductors, electronics, and steel and alloy industries.
Show all investments...

GreyBird Ventures
VC Fund · Concord, Massachusetts, United States · 2 investments in Austria Biotech startups

GreyBird Ventures medical technology firm and invests in companies developing products for precision medicine.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 9
  • Round size: Series A $3M–$16M
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • NeuroKaire — Genetika+ is revolutionzing depression treatment. Using biological, medical and genetic data, GenetikaPlus develops personalized solution for every patient to help them recover better, faster.
  • Platomics — Platomics provides a regulatory compliant digital infrastructure and network for every laboratory to setup and run genetic tests.
  • Angstrom Bio — We Apply Machine Learning And Novel Nucleotide Chemistry to the Diagnosis and Treatment Of Disease. Unparalleled Diagnostic Scale. Better Drugs, Faster.
Show all investments...

Open Field Capital
VC Fund · New York, New York, United States · 2 investments in Austria Biotech startups

Open Field Capital

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Health Care
  • Stage:Series A, Seed
  • Geography: United States, Austria, United Kingdom

Investor stats

  • Total investments: 21
  • Round size: Seed $3.1M–$30M; Series A $8.7M–$52M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • Numenta — Powerful, Neuroscience-Based AI
  • Paragraf — We Work to Develop Innovative and Useful End Products from Novel Materials. Our Analogue Sensors Are Designed to Provide Accurate Field Gradient Mapping & Alignment.
  • Mojo Vision — Mojo Vision is a developer of augmented reality products and platforms intended to invent the future of computing. The company has developed a smart contact lens with a built-in display that gives timely information without interrupting the focus and delivers immediate, powerful, and relevant information without the intrusions of today'smobile devices, enabling users to connect with others at a glance, anytime, anywhere handsfree.Mojo Vision was founded in 2015 and headquartered in Saratoga, California.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
bmp Ventures
VC Fund · Berlin, Berlin, Germany · 2 investments in Austria Biotech startups, 6 in the past 12 months

bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.

Show more...

Investment focus

  • Industry: Software, Information Technology, Manufacturing
  • Stage:Seed, Series A
  • Geography: Germany, United States, Austria

Investor stats

  • Total investments: 120
  • Round size: Seed $165k–$3.4M; Series A $30k–$5.9M
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Sedivention — Fight obesity within 20 minutes - fast, effective, long-term. A new weight-loss therapy for the treatment of obesity. Just a view minutes will change your life.
  • Solar Materials — Solar Materials primarily engages in the development of technologies for the sustainable and economical recycling of solar modules.
  • Litherm Technologies — Fully electric calcination as a pathway to zero-emission lime and cement production.
Show all investments...

R42 Group
VC Fund · Stanford, California, United States · 2 investments in Austria Biotech startups

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United Kingdom, United States, Austria

Investor stats

  • Total investments: 35
  • Round size: Seed $754k–$8M; Pre-Seed $472k–$2M; Series A $4.2M–$40M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • xWatts — xWatts is an intelligent energy management software that reduces energy costs and emissions in commercial buildings.
  • Stamp Free — stampfree.ai Digital Shipping Solutions enables customers to send parcels and returns with just a phone conveniently and securely.
  • Cordance Medical — Improving outcomes for patients with brain diseases
Show all investments...

ICL Planet Startup Hub
VC Fund · Tel Aviv, Tel Aviv, Israel · 2 investments in Austria Biotech startups

ICL Startup Accelerator focuses on foodtech and crop nutrition startups, innovative products, and accelerates their market penetration

Show more...

Investment focus

  • Industry: Biotechnology, Agriculture, AgTech
  • Stage:Seed
  • Geography: Israel, Austria

Investor stats

  • Total investments: 4
  • Round size: Seed $4.3M–$10M
  • Lead/follow: 100% lead, 0% follow

Portfolio highlights

  • Agrematch — Agrematch is a data driven small molecules product discovery, development and marketing company, catering to the agricultural industry. Our novel Ag products discovery engine utilizes big-data science, biology, chemistry, and ag know-how to bring new crop protection products to market.
  • Lavie bio — LaVie Bio develops bacterial compositions that are sprayed on plants, used to coat seeds, or are integrated in the soil around the plant in order to improve the crop or the plant's features.
  • Arkeon Biotechnologies — Arkeon converts CO2 into resources to power tomorrow's industries.
Show all investments...

Ligand Pharmaceuticals
VC Fund · San Diego, California, United States · 2 investments in Austria Biotech startups

A genetic medicines company developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Post-IPO Debt, Corporate Round, Post-IPO Equity
  • Geography: United States, Austria, Denmark

Investor stats

  • Total investments: 19
  • Round size: Post-IPO Debt $15M–$85M; Corporate Round $3M–$10M; Post-IPO Equity $15M–$90M
  • Lead/follow: 58% lead, 42% follow

Portfolio highlights

  • Agenus — Activating the Power of the Immune System to Defeat Cancer
  • Zerion Pharma — Zerion Pharma is a pharmaceutical company that aims to transform the pharmaceutical landscape with a new formulation technology. The company is focused on improving existing drugs by building an internal pipeline to solve the most challenging drug solubility problems that pharmaceutical companies face. Zerion Pharma was founded in 2019 and isbased in Birkerød, Denmark.
  • Castle Creek Biosciences — Dedicated to making life better for people suffering from rare diseases with few or no treatment options
Show all investments...

red-stars.com
VC Fund · 2 investments in Austria Biotech startups

We back B2B software and life-sciences companies with limitless scalability.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Telecommunications
  • Stage:Seed, Series A
  • Geography: Austria, Germany

Investor stats

  • Total investments: 9
  • Round size: Seed $1.8M–$4.4M
  • Lead/follow: 78% lead, 22% follow

Portfolio highlights

  • Txture — IBM Consulting uses IBM Txture to help organizations assess application portfolios, plan cloud modernization and build data-driven transformation strategies.
  • HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
  • MAVOCO — We create a carrier-grade software for IoT champions, trusted by tier-1 Mobile network operators.
Show all investments...

eQventure
VC Fund · Graz, Steiermark, Austria · 2 investments in Austria Biotech startups

Entrepreneurs for Entrepreneurs

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A
  • Geography: Austria, Germany, Switzerland

Investor stats

  • Total investments: 60
  • Round size: Seed $540k–$1.2M; Series A $768k–$6.3M
  • Lead/follow: 77% lead, 23% follow

Portfolio highlights

  • Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
  • Respory — Respory provides real-time people-tracking using proprietary radar sensors, all without capturing personal data. Our scalable sensor network, powered by AI-driven algorithms, delivers precise customer journey insights, critical for in-store performance in retail.
  • 2nd Cycle — 2nd Cycle creating a cost-effective, fully automated, and scalable solution for modules for a second life cycle.
Show all investments...

VP Venture Partners
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Austria Biotech startups

VP Venture Partners is a venture capital firm invests in healthcare companies.

Show more...

Investment focus

  • Industry: Medical, Health Diagnostics, Internet
  • Stage:Seed
  • Geography: Austria, Switzerland

Investor stats

  • Total investments: 7
  • Round size: Seed $3M–$6.9M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Diamens — Diamens is a company focused on femtech that develops a non-invasive menstrual blood-based molecular diagnostic to detect women-specific diseases like endometriosis.
  • Moonlight AI — Moonlight AI was created to democratize the access to genomic information that is essential for therapy decision making in the era of personalized medicine.
  • CollimateHealth — CollimateHealth is creating a clinically scalable microbeam radiation technology that will revolutionize the treatment of cancer.
Show all investments...

BackBone Ventures
VC Fund · Zurich, Zurich, Switzerland · 2 investments in Austria Biotech startups

BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: Switzerland, Germany, Israel

Investor stats

  • Total investments: 74
  • Round size: Seed $966k–$4M; Pre-Seed $578k–$2.8M; Series A $5M–$105M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • eternal.ag — We help greenhouses overcome labor shortages through autonomous harvesting robots so they can keep operations running, every day, at scale.
  • Immitra Bio — Developing scalable in-vivo genomic medicine for blood disorders
  • NextBusiness — NextBusiness makes tools for founders in Switzerland. We build the AI-first business software infinity.swiss.
Show all investments...

Verge HealthTech Fund
VC Fund · Singapore, Central Region, Singapore · 2 investments in Austria Biotech startups

We make early investments in global healthcare technology companies that address prevention, disease management and health system efficiency that are relevant to emerging Asia​We believe that innovation can happen anywhere, from the streets of Dhaka to the labs of Oxford, however without the right support network, these solutions might notscale, or find the best world-changing application. This is where we can help.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Estonia, Singapore, United Kingdom

Investor stats

  • Total investments: 28
  • Round size: Seed $500k–$4.7M; Pre-Seed $500k–$1M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: May invest from a new fund soon — raised $17k in 2021

Portfolio highlights

  • Zoundream — The Future of Infant Care
  • Understanding Zoe — One calm home that remembers for you and grows with your family. Built in Australia for families raising neurodivergent children. Try free for 7 days.
  • Neuraworx Medical Technology — Neuraworx Medical Technology is a neurotechnology company developing first-in-class bioelectronic solutions for brain health.
Show all investments...

Simon Capital
VC Fund · Düsseldorf, Nordrhein-Westfalen, Germany · 2 investments in Austria Biotech startups, 6 in the past 12 months

Simon Capital is an early-stage VC fund with €105M capital ready to invest in innovations that will improve our everyday lives, following the mission of investing “for the next generation”.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Food and Beverage
  • Stage:Series A, Seed, Series B
  • Geography: Germany, Austria, The Netherlands

Investor stats

  • Total investments: 22
  • Round size: Seed $1.8M–$9.3M; Series A $1.7M–$14M; Series B $32M–$57M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — raised $123M in 2022

Portfolio highlights

  • VisioLab — Instantly scan products for self-checkout, using the iPad camera - no barcodes needed. Designed for speed, simplicity and human centricity.
  • Pacifico Biolabs — Pacifico Biolabs offers fermentation biotechnology for development, production and distribution of sustainable and food alternatives.
  • dsb Deutsche Sanierungsberatung — dsb Deutsche Sanierungsberatung provides easy and sustainable solutions for climate-friendly homes energy-efficient renovations for homeowners.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Nina Capital
VC Fund · Barcelona, Catalonia, Spain · 2 investments in Austria Biotech startups, 12 in the past 12 months

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Show more...

Investment focus

  • Industry: Health Care, Artificial Intelligence, Software
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 95
  • Round size: Seed $2M–$6.3M; Pre-Seed $529k–$2.4M; Series A $5M–$21M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • Biobase — Biobase is the agentic system for clinical data, closing the gap between clinical data and outcomes.
  • Ladder Health — Ladder Health offers virtual pediatric therapy and support for early childhood developmental delays, including speech and physical therapy.
  • Woodway Assurance — Woodway Assurance provides EviData, an AI-driven software for automated privacy assurance on de-identified and synthetic datasets.
Show all investments...

KHAN Technology Transfer Fund
VC Fund · Dortmund, Nordrhein-Westfalen, Germany · 2 investments in Austria Biotech startups

KHAN Technology Transfer Fund operates as an investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Biopharma
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Germany, Austria, Luxembourg

Investor stats

  • Total investments: 14
  • Round size: Seed $259k–$10M; Series A $5.6M–$10M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Casinvent Pharma — Casinvent Pharma develops new therapeutic options for the treatment of selected malignancies.
  • iDEL Therapeutics — iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism.
  • KyDo Therapeutics — KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors.
Show all investments...

Arax Capital Partners
VC Fund · Vienna, Wien, Austria · 2 investments in Austria Biotech startups

ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, SaaS
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 6
  • Round size: Seed $1.1M–$1.1M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
  • Greenpass — Greenpass is an all-in-one SaaS for climate-resilient urban planning & architecture platform that enables livable cities.
  • Calyxha Biotechnologies — A new perspective on inflammation
Show all investments...

Hadean Ventures
VC Fund · Oslo, Oslo, Norway · 2 investments in Austria Biotech startups

Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region. The funds are backed by leading private and institutional investors. Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: Norway, Sweden, Austria

Investor stats

  • Total investments: 32
  • Round size: Series A $4.3M–$79M; Series B $4.5M–$75M
  • Lead/follow: 44% lead, 56% follow
  • Last fund: Likely still investing — raised $105M in 2021

Portfolio highlights

  • Step Pharma — Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe.
  • Gesynta Pharma — Founded in 2017, Gesynta Pharma bases its R&D on research from the Karolinska Institutet. The most advanced drug candidate, GS-248, reduces inflammation and increases blood flow in the microvasculature, thereby having the potential to provide improved treatments for several serious diseases. In an ongoing clinical proof-of-concept study,GS-248 is being evaluated for its capacity to normalize vascular blood flow and reduce pain in patients with the autoimmune disease systemic sclerosis. Positive results from this study may lead to a rapid broadening of the development program towards additional indications, for example cardiovascular diseases and rheumatic diseases other than systemic sclerosis. Major shareholders include Industrifonden, Linc, Hadean Ventures, and a number of successful life science entrepreneurs. For more information, please visit www.gesynta.se
  • TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Show all investments...

Longevitytech.fund
VC Fund · Prague, Hlavni mesto Praha, Czech Republic · 2 investments in Austria Biotech startups

Investing globally in technologies extending healthy lifespans

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Life Science
  • Stage:Seed, Convertible Note, Pre-Seed
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 53
  • Round size: Seed $1.8M–$10M; Pre-Seed $100k–$3.6M
  • Lead/follow: 30% lead, 70% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Whytics — DAGI: higher-level causal models from spatiotemporal coarse‑graining Whytics builds tools to reveal and validate macro‑causal structure—the stable, higher-level variables that appear when many parts of a system interact across space and time.
  • Klothea Bio — Klothea Bio is a protein well known for its powerful anti-aging capabilities, such as tumor suppression, neuroprotection, and antioxidative actions. As people age, their klotho levels drop to harmful levels. The metabolic disease syndrome will be the focus of the first investigations, while later studies will try to extend therapeutic applicationsto cancer, Alzheimer's disease, obesity, and other age-related diseases.
  • Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
Show all investments...

SkyGene
VC Fund · Austria, Pangasinan, Philippines · 2 investments in Austria Biotech startups

SkyGene is a venture capital firm. The firm intends to invest in biotech firms.

Show more...

Investment focus

  • Industry: Medical, Health Care, Biotechnology
  • Stage:Venture - Series Unknown
  • Geography: Austria

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • VALANX Biotech — VALANX Biotech is a site-specific protein conjugation platform to enable fast and cost efficient protein-drug-conjugates development.
Show all investments...

Übermorgen Ventures
VC Fund · Zürich, Zurich, Switzerland · 2 investments in Austria Biotech startups

We are an early stage VC for climate tech startups.

Show more...

Investment focus

  • Industry: Energy, Software, SaaS
  • Stage:Seed, Pre-Seed, Series A
  • Geography: Germany, Switzerland, Finland

Investor stats

  • Total investments: 55
  • Round size: Seed $2.1M–$5.9M; Pre-Seed $300k–$4.1M; Series A $2.5M–$12M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Ecair — Ecair provides software for indoor air quality and energy management. The platform aggregates data from connected sensors to track pollutants, CO2, humidity, temperature, and particulate matter in real time. Dashboards, alerts, and APIs support building operations, facility managers, and ESG teams. Algorithms estimate exposure, flag ventilationissues, and suggest HVAC adjustments to balance comfort, health, and energy use. Reporting tools support certifications and compliance, and data exports integrate with BMS, CMMS, and data warehouses. Services include device provisioning, calibration management, and analytics consulting for multi-site portfolios.
  • Verna — Verna is a business using geospatial data science to address the climate and nature crises.We help landowners, investors, and policymakers to use land in ways that draw down carbon, enhance biodiversity and generate sustainable returns – e.g. through woodland creation, habitat creation and enhancement, and regenerative agriculture.Verna wasestablished in Borehamwood, Hertford.
  • Hyperion Robotics — We are accelerating the transition to sustainable and automated construction with Concrete 3D Printing.
Show all investments...

Amino Collective
VC Fund · Berlin, Berlin, Germany · 1 investments in Austria Biotech startups

Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 45
  • Round size: Seed $2.4M–$14M; Pre-Seed $125k–$7.8M; Series A $12M–$37M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Calibre — Diagnostic testing, clinicians, and AI working together to help you deeply understand your health and how to improve it.
  • Modern Relay — Modern Relay provides context graph for enterprise AI.
  • Theorema — Autonomous R&D agents for biotech, pharma, chemicals, and materials. Theorema analyzes data, recovers R&D costs, and accelerates discovery. #1 on BixBench.
Show all investments...

Air Street Capital
VC Fund · London, England, United Kingdom · 1 investments in Austria Biotech startups

Air Street Capital provides venture capital funding and strategic support focused on early-stage companies that develop products based on artificial intelligence. It invests primarily at pre-seed, seed, and Series A stages in firms working on AI-first technology, software infrastructure, machine-learning tools, and AI-enabled life scienceapplications. The firm pairs capital investment with advisory input on product, market, and technology strategy, and facilitates connections to its broader network of AI and technology stakeholders. Air Street Capital also shares industry insights through publications and community initiatives aimed at supporting AI and related tech ecosystems.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States, United Kingdom, France

Investor stats

  • Total investments: 48
  • Round size: Seed $2.6M–$14M; Series A $14M–$48M; Series B $64M–$300M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • STARK — EUROPEAN DEFENCE SOVEREIGNTY
  • Profluent Bio — Profluent Bio is an AI-first protein design company that designs novel, optimal proteins that bypass existing barriers in industry.
  • Macrodata Labs — Reviewing and annotating robotics data by hand does not scale. Macrodata Labs automates QA, subtask annotation, 3D hand tracking, and reward scoring across large robot and egocentric datasets. Send a few sample episodes for a free demo.
Show all investments...

Andera Partners
VC Fund · Paris, Ile-de-France, France · 1 investments in Austria Biotech startups, 12 in the past 12 months

Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Private Equity, Series A
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 185
  • Round size: Series A $7M–$83M; Series B $14M–$85M; Private Equity $110M–$237M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: Likely still investing — raised $466M in 2022

Portfolio highlights

  • Cyllene Therapeutics — EG 427 is a French biotechnology company that pioneers a new approach in gene therapy called pinpoint gene therapy.
  • Inventiva Pharma — Inventiva Pharma is a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of patients with significant unmet medical needs in the areas of fibrosis, lysosomal storage disorders and oncology.They have built a pipeline backed by a discovery engine with an extensive library ofproprietary molecules, a wholly-owned research and development facility and a team with significant expertise and deep experience in the development of compounds that target nuclear receptors, transcription factors and epigenetic modulation. Leveraging these assets and expertise, they are advancing two clinical candidates in three indications, as well as a deep pipeline of earlier stage programs.
  • Rivermark Medical — Rivermark Medical develops a minimally-invasive treatment for Benign Prostatic Hyperplasia (BPH) that restores urinary function. Developed by urologists to reliably reduce BPH symptoms with minimal side effects.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Polaris Partners
VC Fund · Boston, Massachusetts, United States · 1 investments in Austria Biotech startups

Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Ireland, Singapore

Investor stats

  • Total investments: 485
  • Round size: Series A $4.5M–$82M; Series B $7M–$107M; Series C $10M–$107M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — raised $182M in 1998

Portfolio highlights

  • Lob — Lob provides direct mail and address verification APIs that allow businesses to send timely, personalized, automated offline communications to their customers.
  • Jibe — ICIMS is a leading talent acquisition platform offering AI-powered applicant tracking, candidate engagement, onboarding, employer branding, and career site software to help organizations hire top talent at scale.
  • Partnerware — Partnerware maximizes speed-to-market™ for channel-focused companies with the leading B2B Partner Relationship Management (PRM) solution, delivering measurable channel results in Internet time. As a multi-channel sales approach becomes critical in delivering value-added solutions to the marketplace, the need for PRM has grown dramatically.Partnerware provides distinct benefits for companies looking to leverage the power of indirect - Faster channel execution (from channel recruiting to product launches)- Measurable results from partner programs, channel marketing funds, and partner sales efforts- Increased market responsiveness to leap frog and stay ahead of competition- Easy implementation by deploying Web-based Partner Relationship Management solutions in Internet time
Show all investments...

Forbion Capital Partners
VC Fund · Naarden, Noord-Holland, The Netherlands · 1 investments in Austria Biotech startups

Impacting the future of medicine.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, United Kingdom, The Netherlands

Investor stats

  • Total investments: 208
  • Round size: Series A $19M–$180M; Series B $16M–$155M; Series C $19M–$120M
  • Lead/follow: 52% lead, 48% follow
  • Last fund: Likely actively investing — fund raised in 2024

Portfolio highlights

  • Azafaros — Azafaros aims at developing therapeutic agents for the treatment of rare metabolic disorders such as lysosomal storage disorders through oral administration of azasugar compounds. These novel, very promising agents were discovered by Professor Hans Aerts at Leiden University and Amsterdam UMC and are exclusively licensed to Azafaros.
  • Inflazome — Situs gacor premium Megawin188 paling banyak di minati oleh semua kalangan karena pecah selayar tanpa henti dan memiliki tampilan yang sangat memanjakan mata.
  • Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Show all investments...

OrbiMed
VC Fund · New York, New York, United States · 1 investments in Austria Biotech startups

Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, China, Israel

Investor stats

  • Total investments: 653
  • Round size: Series A $10M–$150M; Series B $24M–$150M; Series C $18M–$183M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • CardiAQ Valve Technologies — CardiAQ Valve Technologies (CVT), a privately held company, is developing innovative approaches to heart valve replacement and is initially focused on transcatheter mitral valve implantation (TMVI).
  • Sonendo — Sonendo developing innovative technologies to transform dentistry by Saving Teeth Through Sound Science®. The GentleWave® System shows significant improvements in clinical efficacy and practice efficiency when compared to standard root canal treatment.1,2, 3 Sonendo is the parent company of TDO® Software, the developer of the most widely usedendodontic practice management software in the world, designed to simplify practice workflow. TDO software seamlessly integrates practice management, imaging, social media, referral reporting, CBCT imaging, and offers built-in communication with the GentleWave System.
  • Acceleron Pharma — At Merck, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Show all investments...

Venture Partners AG
VC Fund · Zürich, Zurich, Switzerland · 1 investments in Austria Biotech startups

Venture Partners AG is a leading European Venture firm with locations in Switzerland and Boston.

Show more...

Investment focus

  • Industry: Internet, Software, Biotechnology
  • Stage:Seed, Series B
  • Geography: Austria, United States

Investor stats

  • Total investments: 2
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Allcyte — At Exscientia, we combine the power of AI and human creativity to make safer and more sophisticated drugs available to all. Visit our website to find out more.
  • apps4biz.com — At apps4biz.com™, ease-of-use and affordability are Their passion. They understand that a small business does not have the resources to learn, implement and fully utilize complex systems. apps4biz.com solutions enable you to quickly take advantage of your investment. And, you can easily tailor the apps4biz.com solution to accommodate your businessnow, and as your company grows.
Show all investments...

PONTIS Venture Partners Management
VC Fund · Vienna, Wien, Austria · 1 investments in Austria Biotech startups

PONTIS Capital manages two funds with total commitments of more than EUR 60 million, and is actively investing out of its second fund, PONTIS Growth Capital II (“PGC II”). The focus of PGC II is to invest in small and medium-sized growth companies with Established technology or other competitive advantage Existing proof-of-market in marketswith growth potential,Scalable business models, andHeadquarters in the DACH region (Germany, Austria, Switzerland)

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Series B, Series C
  • Geography: Austria, Germany

Investor stats

  • Total investments: 5
  • Lead/follow: no public data

Portfolio highlights

  • evidanza — evidanza GmbH is a software provider of business intelligence solutions for reporting, planification, OLAP-analysis, risk management, costs calculations, IFRS- and USGAAP-reporting. The company is headquartered in Salching, Germany.
  • SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
  • EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
Show all investments...

IPO Beteiligungs-Management
VC Fund · Vienna, Wien, Austria · 1 investments in Austria Biotech startups

IPO Beteiligungs-Management is a private equity company specialized in early stage venture investments.

Show more...

Investment focus

  • Industry: Sensor, Medical, Wireless
  • Stage:Series B
  • Geography: Austria

Investor stats

  • Total investments: 2
  • Lead/follow: no public data

Portfolio highlights

  • SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
  • EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
Show all investments...

Axilium Holding
VC Fund · 1 investments in Austria Biotech startups

Axilium Holding

Show more...

Investment focus

  • Industry: Life Science, Biotechnology, Semiconductor
  • Stage:Seed
  • Geography: Austria

Investor stats

  • Total investments: 1
  • Lead/follow: no public data

Portfolio highlights

  • Sarcura — Sarcura GmbH is an Austrian deep-tech startup developing an instrument platform for the industrial manufacturing of advanced cell therapies. Our platform combines silicon chip technology and microfluidic processing to enable real-time process control and manipulation on a cellular level, enabling a fully automated and modular manufacturing system..
Show all investments...

IBG Beteiligungsgesellschaft Sachsen-Anhalt
VC Fund · Magdeburg-rothensee, Sachsen-Anhalt, Germany · 1 investments in Austria Biotech startups

IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.

Show more...

Investment focus

  • Industry: Electronics, Software, Medical Device
  • Stage:Seed, Series A
  • Geography: Germany, Austria

Investor stats

  • Total investments: 12
  • Lead/follow: no public data

Portfolio highlights

  • Livil — Livil provides a toolkit for designing and delivering flexible employee benefits, including lifestyle, dental, and vision plans.
  • Wingfield — Wingfield develops a system intended to transform any tennis court in the world into a smart court. The system is a combination of hardware and artificial intelligence and keeps track of the score, analyzes strokes and gives personal feedback right after matches or practice sessions and the system only costs a fraction of a professional system andis easily set up, enabling players to get the same game analytics as the professionals do.
  • Baby Sweets — Baby Sweets provides Online shop for beautiful and unusual baby clothes and accessories.Sales of own brands made in EU as well as international brands.
Show all investments...

ReGen Ventures
VC Fund · Byron Bay, New South Wales, Australia · 1 investments in Austria Biotech startups

Investing in the ReGeneration

Show more...

Investment focus

  • Industry: Agriculture, Biotechnology, Farming
  • Stage:Seed, Series A, Series B
  • Geography: United States, Austria, United Kingdom

Investor stats

  • Total investments: 19
  • Lead/follow: no public data

Portfolio highlights

  • Anthrogen — Anthrogen is a Biotechnology Research firm using bacteria and enzymes for reducing carbon in the air by transforming it into chemicals.
  • Asterix Foods — Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel.
  • Differential Bio — Differential Bio is integrating scale-down experiments with AI-based modeling to optimize how industry-relevant microbes grow ("biomass fermentation") and produce ("precision fermentation"). By optimizing bioprocesses and growth conditions, the company is not only increasing their clients' R&D efficiency but alsodramatically improving bioproduction outcomes such as yield, cost efficiency, and product quality.
Show all investments...

Climentum Capital
VC Fund · Copenhagen, Hovedstaden, Denmark · 1 investments in Austria Biotech startups

A Venture Capital firm investing into European early-stage tech companies attacking CO2 emissions

Show more...

Investment focus

  • Industry: CleanTech, Clean Energy, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: Sweden, Spain, Austria

Investor stats

  • Total investments: 16
  • Lead/follow: no public data

Portfolio highlights

  • Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
  • Wayout International — WAYOUT offers complete water production systems for local coverage of perfect drinking water on a commercial platform with minimal eco footprint.
  • ZeroPoint Technologies — ZeroPoint Technologies AB was created in 2016 as a spinout from Chalmers University of Technology. The Intellectual Property Portfolio related to computer memory management was the acquired from the University and transferred into a new startup.The Technology, ideas and many of the people behind and with ZeroPoint comes from Professor PerStenströms research group, which is internationally recognized for excellence within high-performance Computing. Since its creation, ZeroPoint has attracted skilled people from industry, finance and the startup community and raised its’ first round of Venture Capital in 2016.
Show all investments...

Biotech Investor funding in Austria at a glance

Stats across 166 deals from 191 investors.

191
investors
in Austria Biotech startups
166
deals
in Austria Biotech startups
$3.2M
median round
in Austria Biotech startups
48%
lead investors
lead at least one round
29%
Seed
most common funding stage
96/4
VC / Angel
share of investor count

Access all 191 investors in Austria Biotech startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotech Investors in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 191 investors investing in Austria Biotech startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists